biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Sep 16, 2016 4:45pm

105 Views

Post# 25246811

RE:RE:RE:RE:RE:RE:Regardless - the idiot

,,KBC,,,,,,,,,,"I have missed the opportunity to buy at .70 cents???".....hummmm,,,,,,woy you talking about?,,,,,get real,,,,,,the only way one sees a missed opportunity is hindsight my friend,,

Hindsight? LOL. Nice try. I posted this to you on Jan 30th, 2014, the same day it hit 70¢.

"....This is just scared retail investors selling at the bottom. I'm going to remind you of this missed opportunity to buy BTI in the 70¢ to 75¢ range, and how you got it exactly wrong...."

That's OK. As I said, I'm expecting lots of revisionist history.

Bullboard Posts

Barrick Gold employees detained in Mali amid ongoing dispute